• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度医疗保险状况与冠状动脉危险因素、冠状动脉疾病、干预措施及预后的关联

Association of health insurance status with coronary risk factors, coronary artery disease, interventions and outcomes in India.

作者信息

Gupta Rajeev, Makkar Jitender S, Sharma Sanjeev K, Agarwal Ansh, Sharma Krishna K, Bana Ajeet, Kasliwal Atul, Sidana Sanjeev K, Degawat Prem Ratan, Bhagat Kush K, Natani Vishnu, Khedar Raghubir S, Sharma Samin K

机构信息

Departments of Cardiology, Eternal Heart Care Centre and Research Institute, Jaipur, 302017, India.

Departments of Internal Medicine, Eternal Heart Care Centre and Research Institute, Jaipur, 302017, India.

出版信息

Int J Cardiol Cardiovasc Risk Prev. 2022 Aug 13;14:200146. doi: 10.1016/j.ijcrp.2022.200146. eCollection 2022 Sep.

DOI:10.1016/j.ijcrp.2022.200146
PMID:36060285
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9434410/
Abstract

OBJECTIVE

Coronary artery disease (CAD) related hospitalization and interventions are associated with catastrophic out-of-pocket health expenditure in India. To evaluate differences in risk factors, disease severity, management and outcomes in uninsured vs insured CAD patients we performed a study.

METHODS

Successive CAD patients who underwent percutaneous intervention (PCI) at our centre were enrolled from January 2018 to June 2021. Clinical, angiographic and intervention data were periodically uploaded in the American College of Cardiology CathPCI platform. Descriptive statistics are reported.

RESULTS

4672 CAD patients (men 3736, women 936) were included; uninsured were 2166 (46%), government insurance was in 1635 (36%) and private insurance in 871 (18%). Mean age was 60.1 ± 11 years, uninsured <50y were 21.6% vs 14.0% and 20.3% with government and private insurance. Among the uninsured prevalence of raised total and non-HDL cholesterol, any tobacco use, ST-elevation myocardial infarction (STEMI) and ejection fraction <30% were more (p < 0.01). In the STEMI group (n = 1985), rates of primary PCI were the highest in those with private insurance (38.7%) compared to others. Multivessel stenting (≥2 stents) was more among the insured patients. Median length of hospital stay was similar in the three groups. In-hospital mortality was slightly more in the uninsured (1.43%), compared to government (0.88) and privately insured (0.82) (p = 0.242). The cost of hospitalization and procedures was the highest among uninsured (US$ 2240, IQR 1877-2783) compared to government (US$ 1977, IQR 1653-2437) and privately insured (US$ 2013, IQR 1668-2633) (p < 0.001).

CONCLUSIONS

Uninsured CAD patients in India are younger with more risk factors, acute coronary syndrome, STEMI, multivessel disease and coronary stenting compared to those with government or private insurance. The uninsured bear significantly greater direct costs with slightly greater mortality.

摘要

目的

在印度,冠心病(CAD)相关住院治疗和干预与灾难性的自付医疗费用有关。为评估未参保与参保CAD患者在危险因素、疾病严重程度、治疗及结局方面的差异,我们开展了一项研究。

方法

连续纳入2018年1月至2021年6月在我院中心接受经皮冠状动脉介入治疗(PCI)的CAD患者。临床、血管造影及介入治疗数据定期上传至美国心脏病学会CathPCI平台。报告描述性统计结果。

结果

共纳入4672例CAD患者(男性3736例,女性936例);未参保者2166例(46%),政府医保覆盖者1635例(36%),私人医保覆盖者871例(18%)。平均年龄为60.1±11岁,未参保者中年龄<50岁者占21.6%,而政府医保和私人医保覆盖者中这一比例分别为14.0%和20.3%。在未参保者中,总胆固醇及非高密度脂蛋白胆固醇升高、任何形式的烟草使用、ST段抬高型心肌梗死(STEMI)及射血分数<30%的患病率更高(p<0.01)。在STEMI组(n=1985)中,私人医保覆盖者的直接PCI率最高(38.7%),高于其他组。多支血管支架置入(≥2枚支架)在参保患者中更为常见。三组患者的住院中位时长相似。未参保者的院内死亡率略高于政府医保覆盖者(1.43%对0.88%)和私人医保覆盖者(0.82%)(p=0.242)。未参保者的住院及治疗费用最高(2240美元,四分位数间距1877 - 2783美元),高于政府医保覆盖者(1977美元,四分位数间距1653 - 2437美元)和私人医保覆盖者(2013美元,四分位数间距1668 - 2633美元)(p<0.001)。

结论

与政府医保或私人医保覆盖的CAD患者相比,印度未参保的CAD患者更年轻,危险因素更多,急性冠状动脉综合征、STEMI、多支血管病变及冠状动脉支架置入的比例更高。未参保者承担的直接费用显著更高且死亡率略高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f20c/9434410/7d810358eaae/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f20c/9434410/50beb1dc910f/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f20c/9434410/4922d8195c6c/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f20c/9434410/7d810358eaae/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f20c/9434410/50beb1dc910f/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f20c/9434410/4922d8195c6c/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f20c/9434410/7d810358eaae/gr3.jpg

相似文献

1
Association of health insurance status with coronary risk factors, coronary artery disease, interventions and outcomes in India.印度医疗保险状况与冠状动脉危险因素、冠状动脉疾病、干预措施及预后的关联
Int J Cardiol Cardiovasc Risk Prev. 2022 Aug 13;14:200146. doi: 10.1016/j.ijcrp.2022.200146. eCollection 2022 Sep.
2
Influence of COVID-19 pandemic in India on coronary artery disease clinical presentation, angiography, interventions and in-hospital outcomes: a single centre prospective registry-based observational study.印度 COVID-19 大流行对冠心病临床表现、血管造影、介入治疗和住院结局的影响:一项基于单中心前瞻性登记的观察性研究。
BMJ Open. 2024 Mar 29;14(3):e078596. doi: 10.1136/bmjopen-2023-078596.
3
API expert consensus document on management of ischemic heart disease.缺血性心脏病管理的API专家共识文件
J Assoc Physicians India. 2006 Jun;54:469-80.
4
Premature coronary artery disease, risk factors, clinical presentation, angiography and interventions: Hospital based registry.早发性冠状动脉疾病、危险因素、临床表现、血管造影和介入治疗:基于医院的注册研究。
Indian Heart J. 2022 Sep-Oct;74(5):391-397. doi: 10.1016/j.ihj.2022.08.003. Epub 2022 Aug 19.
5
Influence of primary payer status on the management and outcomes of ST-segment elevation myocardial infarction in the United States.美国初级支付者身份对 ST 段抬高型心肌梗死的管理和结局的影响。
PLoS One. 2020 Dec 18;15(12):e0243810. doi: 10.1371/journal.pone.0243810. eCollection 2020.
6
In-Hospital Management and Outcomes After ST-Segment-Elevation Myocardial Infarction in Medicaid Beneficiaries Compared With Privately Insured Individuals.与私人保险个体相比,医疗补助受益人的ST段抬高型心肌梗死院内管理及预后
Circ Cardiovasc Qual Outcomes. 2019 Jan;12(1):e004971. doi: 10.1161/CIRCOUTCOMES.118.004971.
7
Microeconomic Costs, Insurance, and Catastrophic Health Spending Among Patients With Acute Myocardial Infarction in India: Substudy of a Randomized Clinical Trial.印度急性心肌梗死患者的微观经济成本、保险和灾难性卫生支出:一项随机临床试验的子研究。
JAMA Netw Open. 2019 May 3;2(5):e193831. doi: 10.1001/jamanetworkopen.2019.3831.
8
Determinants of bare-metal stent use in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.ST段抬高型心肌梗死患者接受直接经皮冠状动脉介入治疗时裸金属支架使用的决定因素。
J Invasive Cardiol. 2013 Mar;25(3):114-7.
9
Association of health insurance status with presentation and outcomes of coronary artery disease among nonelderly adults undergoing percutaneous coronary intervention.健康保险状况与接受经皮冠状动脉介入治疗的非老年成年人冠心病患者临床表现和结局的相关性研究。
Am Heart J. 2011 Sep;162(3):512-7. doi: 10.1016/j.ahj.2011.06.002. Epub 2011 Jul 26.
10
Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease.罪犯血管经皮冠状动脉介入治疗与多血管和分期经皮冠状动脉介入治疗 ST 段抬高型心肌梗死合并多血管病变患者。
JACC Cardiovasc Interv. 2010 Jan;3(1):22-31. doi: 10.1016/j.jcin.2009.10.017.

引用本文的文献

1
Chronic statin-use before PCI in acute coronary syndromes and in-hospital outcomes: ACC-NCDR registry in India.急性冠状动脉综合征患者PCI术前长期使用他汀类药物与住院结局:印度ACC-NCDR注册研究
Am J Prev Cardiol. 2025 Apr 19;22:100999. doi: 10.1016/j.ajpc.2025.100999. eCollection 2025 Jun.
2
Adherence to pharmacotherapy for secondary prevention of coronary heart disease: A registry-based prospective study.冠心病二级预防药物治疗的依从性:一项基于登记处的前瞻性研究。
Indian Heart J. 2025 Mar-Apr;77(2):84-88. doi: 10.1016/j.ihj.2025.02.009. Epub 2025 Feb 26.
3
Strengthening cardiac services in Faridabad District: A facility mapping exercise to explore implementation of a hub-and-spoke model.

本文引用的文献

1
Erratum to: Issues in Public Health in India - Keynote address by Keshav Desiraju, Former Secretary of Health and Family Welfare to the Government of India and Is there an opioid epidemic in India?勘误:《印度公共卫生问题——印度卫生与家庭福利部前秘书凯沙夫·德西拉朱的主题演讲》以及《印度存在阿片类药物流行问题吗?》
J Public Health (Oxf). 2022 Mar 7;44(1):e167. doi: 10.1093/pubmed/fdab391.
2
Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study.全球心血管疾病负担及危险因素, 1990-2019:来自 GBD 2019 研究的更新。
J Am Coll Cardiol. 2020 Dec 22;76(25):2982-3021. doi: 10.1016/j.jacc.2020.11.010.
3
强化法里达巴德地区的心脏服务:一项设施绘图研究,旨在探索枢纽辐射模式的实施。
Indian J Med Res. 2024;159(3 & 4):347-355. doi: 10.25259/IJMR_1789_23.
4
Do patients need additional coverage for chronic ailments? Insights from hospital data.慢性病患者是否需要额外的保险覆盖?来自医院数据的见解。
J Educ Health Promot. 2024 Jul 5;13:174. doi: 10.4103/jehp.jehp_34_24. eCollection 2024.
5
Factors influencing the intention to purchase health insurance: a study of Indian tobacco and alcohol consumers.影响健康保险购买意愿的因素:一项针对印度烟草和酒精消费者的研究。
Front Public Health. 2024 Mar 15;12:1332511. doi: 10.3389/fpubh.2024.1332511. eCollection 2024.
6
Influence of COVID-19 pandemic in India on coronary artery disease clinical presentation, angiography, interventions and in-hospital outcomes: a single centre prospective registry-based observational study.印度 COVID-19 大流行对冠心病临床表现、血管造影、介入治疗和住院结局的影响:一项基于单中心前瞻性登记的观察性研究。
BMJ Open. 2024 Mar 29;14(3):e078596. doi: 10.1136/bmjopen-2023-078596.
7
Low body mass index is associated with adverse cardiovascular outcomes following PCI in India: ACC-NCDR registry.低体重指数与印度经皮冠状动脉介入治疗后的不良心血管结局相关:美国心脏病学会-国家心血管数据注册库。
Int J Cardiol Cardiovasc Risk Prev. 2023 Dec 14;20:200230. doi: 10.1016/j.ijcrp.2023.200230. eCollection 2024 Mar.
Availability and affordability of medicines and cardiovascular outcomes in 21 high-income, middle-income and low-income countries.
21 个高收入、中等收入和低收入国家的药品可及性和可负担性与心血管结局的关系。
BMJ Glob Health. 2020 Nov;5(11). doi: 10.1136/bmjgh-2020-002640.
4
Epidemiology of Ischemic Heart Disease and Diabetes in South Asia: An Overview of the Twin Epidemic.南亚热带缺血性心脏病和糖尿病的流行病学:双重流行概述。
Curr Diabetes Rev. 2021;17(9):e100620186664. doi: 10.2174/1573399816666201006144606.
5
On the path to Universal Health Coverage: aligning ongoing health systems reforms in India.通往全民健康覆盖之路:协调印度正在进行的卫生系统改革
BMJ Glob Health. 2020 Sep;5(9). doi: 10.1136/bmjgh-2020-003801.
6
The Lancet NCDI Poverty Commission: bridging a gap in universal health coverage for the poorest billion.《柳叶刀》非传染性疾病与贫困问题委员会:弥合最贫困的十亿人口在全民健康覆盖方面的差距。
Lancet. 2020 Oct 3;396(10256):991-1044. doi: 10.1016/S0140-6736(20)31907-3. Epub 2020 Sep 14.
7
Resource and Infrastructure-Appropriate Management of ST-Segment Elevation Myocardial Infarction in Low- and Middle-Income Countries.资源与基础设施适宜化管理:中低收入国家 ST 段抬高型心肌梗死
Circulation. 2020 Jun 16;141(24):2004-2025. doi: 10.1161/CIRCULATIONAHA.119.041297. Epub 2020 Jun 15.
8
Are cost advantages from a modern Indian hospital transferable to the United States?印度现代化医院的成本优势能转移到美国吗?
Am Heart J. 2020 Jun;224:148-155. doi: 10.1016/j.ahj.2020.04.009. Epub 2020 Apr 21.
9
The household economic burden of non-communicable diseases in 18 countries.18 个国家的非传染性疾病家庭经济负担
BMJ Glob Health. 2020 Feb 11;5(2):e002040. doi: 10.1136/bmjgh-2019-002040. eCollection 2020.
10
Challenges in management and prevention of ischemic heart disease in low socioeconomic status people in LLMICs.中低收入国家中社会经济地位较低人群的缺血性心脏病管理和预防面临的挑战。
BMC Med. 2019 Nov 26;17(1):209. doi: 10.1186/s12916-019-1454-y.